Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,364 | 98 | 98.8% |
| Education | $16.45 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $341.73 | 15 | $0 (2023) |
| Amarin Pharma Inc. | $294.54 | 21 | $0 (2022) |
| Hikma Pharmaceuticals USA | $183.00 | 28 | $0 (2022) |
| Novo Nordisk Inc | $91.97 | 6 | $0 (2023) |
| Lilly USA, LLC | $64.27 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $55.42 | 3 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $52.54 | 4 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $52.24 | 3 | $0 (2018) |
| Noden Pharma USA Inc | $49.57 | 3 | $0 (2017) |
| Daiichi Sankyo Inc. | $41.79 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $71.95 | 4 | GlaxoSmithKline, LLC. ($20.30) |
| 2022 | $221.79 | 31 | Hikma Pharmaceuticals USA ($142.89) |
| 2021 | $230.06 | 16 | Amarin Pharma Inc. ($122.01) |
| 2020 | $172.47 | 12 | Amarin Pharma Inc. ($139.55) |
| 2019 | $12.73 | 1 | AstraZeneca Pharmaceuticals LP ($12.73) |
| 2018 | $349.91 | 20 | Amgen Inc. ($193.93) |
| 2017 | $321.39 | 16 | Amgen Inc. ($133.52) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Diabetes | ||||||
| 02/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 01/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Bone Health | ||||||
| 12/06/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/03/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/20/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug), Ryaltris | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2022 | Hikma Pharmaceuticals USA | Ryaltris (Drug), Mitigare | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/28/2022 | Hikma Pharmaceuticals USA | Ryaltris (Drug), Mitigare | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/20/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/01/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Cardiovascular | ||||||
| 08/04/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/06/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $3.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/08/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Diabetes | ||||||
| 05/18/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 118 | 130 | $17,130 | $6,579 |
| 2022 | 7 | 401 | 576 | $67,925 | $33,387 |
| 2021 | 12 | 549 | 719 | $76,875 | $37,555 |
| 2020 | 7 | 509 | 707 | $64,650 | $27,569 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $9,800 | $3,656 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 73 | $7,040 | $2,679 | 38.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 29 | $290.00 | $243.60 | 84.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 198 | $18,810 | $12,255 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $22,925 | $9,001 | 39.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 39 | 39 | $13,110 | $6,683 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 50 | $8,500 | $4,335 | 51.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 104 | 157 | $1,570 | $465.63 | 29.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 48 | $2,160 | $459.07 | 21.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $850.00 | $188.12 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 89 | 89 | $30,925 | $12,205 | 39.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 114 | 194 | $18,235 | $11,584 | 63.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 37 | $6,290 | $3,753 | 59.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 21 | 21 | $7,275 | $3,649 | 50.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 34 | 44 | $4,410 | $1,703 | 38.6% |
| 90653 | Vaccine for influenza for injection into muscle, inactivated | Office | 2021 | 27 | 27 | $2,025 | $1,607 | 79.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 15 | 15 | $1,240 | $980.02 | 79.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 51 | 51 | $1,570 | $896.07 | 57.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 91 | 150 | $1,500 | $450.00 | 30.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 27 | 43 | $1,935 | $421.86 | 21.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 16 | 17 | $850.00 | $198.42 | 23.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 30 | 31 | $620.00 | $107.88 | 17.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 102 | 102 | $35,700 | $12,174 | 34.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 112 | 188 | $15,980 | $8,370 | 52.4% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 75 | 79 | $5,875 | $4,677 | 79.6% |
About Dr. Cyril Wolf, MD
Dr. Cyril Wolf, MD is a Family Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104890318.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cyril Wolf, MD has received a total of $1,380 in payments from pharmaceutical and medical device companies, with $71.95 received in 2023. These payments were reported across 100 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,364).
As a Medicare-enrolled provider, Wolf has provided services to 1,577 Medicare beneficiaries, totaling 2,132 services with total Medicare billing of $105,090. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Houston, TX
- Active Since 02/14/2006
- Last Updated 12/21/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104890318
Products in Payments
- Vascepa (Drug) $294.54
- Repatha (Biological) $284.72
- Mitigare (Drug) $173.94
- Rybelsus (Drug) $63.12
- PRALUENT ALIROCUMAB INJECTION (Biological) $52.54
- Tekturna (Drug) $49.57
- EMGALITY (Drug) $47.15
- Xofluza (Drug) $39.31
- Prolia (Biological) $38.73
- PRALUENT (Drug) $35.23
- Ozempic (Drug) $28.85
- FreeStyle Libre Pro (Device) $27.80
- Movantik (Drug) $24.16
- SYMBICORT (Drug) $22.60
- TRELEGY ELLIPTA (Drug) $20.30
- BEVESPI AEROSPHERE (Drug) $20.09
- BREO (Drug) $18.67
- Tirosint (Drug) $18.47
- Welchol (Drug) $17.63
- ENTRESTO (Drug) $17.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Houston
Shannon Schrader, Md, MD
Family Medicine — Payments: $383,042
Dr. Eric Nolen, Md, Mba, MD, MBA
Family Medicine — Payments: $158,026
Candice Winful, M.d, M.D
Family Medicine — Payments: $123,290
Dr. Joe Pouzar, M.d, M.D
Family Medicine — Payments: $104,957
Victor Escobar, M.d, M.D
Family Medicine — Payments: $79,840
Dr. Oscar De Valle, M.d, M.D
Family Medicine — Payments: $78,226